Clinical Trials

Clinical Trials for KZR-616

KZR-616 is currently being evaluated in Phase 2 clinical trials for the treatment of lupus nephritis and dermatomyositis/polymyositis. Find out how KZR-616 works to harmonize the immune system.

A Phase 1b/2 Study of KZR-616 in Patients With Systemic Lupus Erythematosus with and without Nephritis

Recruiting

A Phase 1b/2 Study of KZR-616 in Patients With Systemic Lupus Erythematosus with and without Nephritis

More Information
A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients with Active Polymyositis or Dermatomyositis

Recruiting

A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients with Active Polymyositis or Dermatomyositis

More Information